Dave Weiner

Stock Analyst at Piper Sandler

(1.92)

# 2,951

Out of 4,837 analysts

8

Total ratings

66.67%

Success rate

n/a

Average return

Main Sectors:

Healthcare Consumer Discretionary

Top Industries:

Diagnostics & Research Apparel Retail

Stocks Rated by Dave Weiner

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MYGN Myriad Genetics	Maintains: Overweight	$13 → $9	$4.45	+102.25%	3	May 15, 2025
	LULU lululemon athletica inc.	Upgrades: Buy	n/a	$327.17	-	5	Dec 14, 2017

Myriad Genetics

May 15, 2025

Maintains: Overweight

Price Target: $13 → $9

Current: $4.45

Upside: +102.25%

lululemon athletica inc.

Dec 14, 2017

Upgrades: Buy

Price Target: n/a

Current: $327.17

Upside: -